BNET Industries
Market Cap:$240.7M
Last Fiscal Year Sales:$16.1M
- Public
- US
Dow Jones Description
We are developing ZFP TFs for direct use in the patient to either turn on therapeutically beneficial genes or turn off the expression of disease-causing .
Number of Employees 77
Contact Information
Point Richmond Tech Ctr II 501 Canal Blvd Ste A100
Richmond, California 94804
(510) 970-6000
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
Recent Events
-
Sangamo SGMO Reports Q3 Loss of $0.12, Beats by 1c
-
BUYINS.NET: BTI, BPFH, TYL, EEFT, OSTK, SGMO Expected To Be Higher After Earnings Releases on...
-
Sigma-Aldrich profit up, sales drop slightly
-
Sangamo BioSciences raises $21.6 million in public offering
-
Sangamo BioSciences, Inc. SGMO Lands $20 Million in Expanded Sigma-Aldrich Corporation SIAL Deal
-
Sigma-AldrichR and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement Sigma-Aldrich to Exclusively...
-
Sangamo BioSciences Reports Second Quarter 2009 Financial Results
-
Sangamo BioSciences, Inc. SGMO Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech,...
News & Analysis
Filter by
sangamo biosciences inc. - All News and Analysis
Sangamo Biosciences, Inc. Q3 2009 Earnings Call Transcript
Seeking Alpha
- 2009-11-04
Question-and-Answer Session Operator Operator Instructions. First up is Charles Duncan, JMP Securities. Charles Duncan - JMP Securities My first question is regarding the Sigma or the traction Sigma is getting, Edward I was at site for neuroscience and there was a surprise out of that, and then I...
Sangamo BioSciences, Inc. Q2 2009 Earnings Call Transcript
Seeking Alpha
- 2009-07-29
Question-and-Answer SessionOperator Operator instructions We'll move first to Joe Pantginis with Merriman Curhan Ford. Joe Pantginis – Merriman Curhan Ford Quick question on the 509 program and then a follow-up on the non-therapeutic platform. Just wondering if we can have a little glimpse into the future, now that you...
Sangamo BioSciences, Inc. Q2 2009 Earnings Call Transcript
Seeking Alpha
- 2009-07-29
Sangamo BioSciences, Inc. SGMO Q2 2009 Earnings Call Transcript July 29, 2009 5:00 pm ET
Sangamo Biosciences, Inc. Q1 2009 Earnings Call Transcript
Seeking Alpha
- 2009-04-29
Question-and-Answer SessionOperator Operator instructions We will go to Charles Duncan with JMP Securities. Edward Lanphier Hello? Why don't we go to our next question please? Operator We will take our next question from Eric Barma [ph] with Leerink Swann. Eric Barma – Leerink Swann Hi, good evening, guys, can...
Sangamo Biosciences Inc. Q4 2008 Earnings Call Transcript
Seeking Alpha
- 2009-02-04
Question-and-Answer SessionOperator Thank you. Operator Instructions We’ll go first to Charles Duncan with JMP Securities. Charles Duncan - JMP Securities Hi guys, thanks for taking my question and very good job on managing the cash in a very good way. I actually have a question on the cash. I...
Pfizer Gives Sangamo a Vote of Confidence
Seeking Alpha
- 2008-12-22
Sangamo SGMO announced today it received an upfront payment of $3M from Pfizer PFE in exchange for a world-wide, perpetual, non-exclusive license for the use of certain ZFP Nuclease (ZFN) reagents to permanently eliminate the Glutamine Synthetase (GS) gene in Chinese Hamster ovary CHO cell lines. Shares are...
Sangamo Biosciences Inc. Q3 2008 Earnings Call Transcript
Seeking Alpha
- 2008-10-29
Question-and-Answer SessionOperator Operator instructions Your first question comes from Charles Duncan with JMP Securities. Charles Duncan – JMP Securities Congratulations on some good progress in the quarter and that’s for taking the call. I had a first question about the balance sheet. Can you give us a little bit...
Zacks Analyst Blog Highlights: Everest Re Group, Ltd., State Auto Financial Corp., Sangamo Biosciences, Inc., Lloyds TSB Group Plc. and HBOS Plc
- 2008-10-13
CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Everest Re Group, Ltd. (NYSE: RE), State Auto Financial Corp. (Nasdaq:...
Zacks Bull and Bear of the Day Highlights: St. Jude Medical, AAR Corp., Sangamo Biosciences, State Auto Financial and Robert Half
- 2008-10-10
CHICAGO -- Zacks Equity Research highlights St. Jude Medical (NYSE: STJ) as the Bull of the Day and AAR Corporation (NYSE: AIR) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Sangamo Biosciences, Inc. (Nasdaq: SGMO), State Auto Financial Corporation (Nasdaq: STFC) and Robert Half...
Sangamo Biosciences Inc. Q2 2008 Earnings Call Transcript
Seeking Alpha
- 2008-07-28
Question-and-Answer SessionOperator Operator instructions And we'll go first to Charles Duncan with JMP Securities. Charles Duncan - JMP Securities Good afternoon, folks, and congratulations on a very productive quarter. Edward Lanphier Thanks, Charles. Charles Duncan - JMP Securities I had one quick question on DAS and one on 509....
- 1
- 2
Industry Transcripts by Seeking Alpha
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
-
Arena Pharmaceuticals Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ARNA
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
